Monday, June 15, 9:00 – 10:30 pm
Auditorium Lulli

1. EO of cancer: what should we do know for screening, prevention and early diagnosis 
2. After neoadjuvent therapy with (n)cCR, local endoscopic resections? 
3. Pro: First joice Chemo (instead of CROSS) in adenocarcinoma of esophagus 
4. Contra: First joice CROSS (instead Chemo) in adenocarcinoma of esophagus
5. De-escalation strategies: ATTENUATION or FLOT-like combinations 
6. Adjuvant therapy - an option after missed neodjuvant therapy?
7. MSI: how do we treat, w+w or operate? 
8. ASCO 2026: New important SOC-changing phase III trials?
9. Multidisciplinary Tumor Board-Harmonizing other Local and Systemic Control in Gastric or Gastroesophageal Cancer 
10. Decision making and translational research: Challenges and evidence in tumor conferences 
11. Sport program and Resilience: what helps in perioperative setting? 

Monday, June 15, 9:00 – 10:30 am
Auditorium Richelieu

1. Belch or no belch: what is the approach to belching disorders?
2. When to suspect and confirm the diagnosis of rumination?
3. How does symptom-specific anxiety and hypervigilance intersect with esophageal conditions?
4. What is the role of brain-gut behavioral therapy in treating esophageal symptoms?
5. How to leverage pharmacologic neuromodulation for esophageal symptoms?
6. Are there roles for complementary therapies such as acupuncture and nerve stimulation for treating esophageal conditions?

Panel Chat/Q&A

Monday, June 15, 11:00 am – 12:30 pm
Auditorium Richelieu

1. How should non-cardiac chest pain be diagnosed?
2. How is functional heartburn different from reflux-induced heartburn?
3. Should reflux hypersensitivity be managed as a DGBI, GERD, or both? 
4. Is globus a LPRD symptom or a primary DGBI?
5. What test(s) should be performed to diagnose functional dysphagia?
6. How does functional dyspepsia overlap with esophageal symptoms or disorders?

Panel Chat/Q&A

Monday June 15, 11:00 am – 12:30 pm
Auditorium Condé

   I. POEM and Third-Space Procedures

1. Does the side of mucosal entry affect POEM procedure outcomes? 
2. What is the true incidence of reflux after POEM & how can that be reduced? 
3. Does it matter whether full-thickness or circular muscle-only myotomy is performed for POEM? 
4. Do we know the long-term durability of POEM? 
5. Can we predict which patients will fail POEM? 
6. Should we aim for same day discharge after POEM? 
   
   
   II. Endoscopic Submucosal Dissection & Tumor Resection
    
7. How large is too large for ESD in 2026? 
8. How deep is too deep for ESD in 2026?
9. Is endoscopic ultrasound helpful or required for optimal ESD? 
10. Will artificial intelligence change the way we perform ESD?
11. What technological advances are needed for ESD to make the next leap forward? 
12. What are the next steps for 3rd space endoscopy in the esophagus? 

Monday, June 15, 2:00 – 3:30 pm
Auditorium Lulli

Talks:

1. What does the San Diego Consensus change in clinic?  
2. Is GMA biomarker subtyping the key to understanding and treating GERD/LPR?  
3. Alginate, H2RA, PPI, neuromodulation, or lifestyle first—what’s your first script? 
4. What is the current understanding of the role of reflux in promoting laryngopharngeal cancer? 
5. Are PCABs effective for LPRD?  
6. What is the status of pepsin inhibitors for LPR? 
7. Which surgical or endoscopic options work for extra-esophageal disease?
8. Pediatrics: are kids just little adults when it comes to LPRD?

Motion: "This house supports the San Diego Consensus Statement as the governing guideline for LPRD."

• FOR: (defending the Consensus statements & pathways). 
• AGAINST: (challenging external validity, symptom-first pathways, and laryngology-specific nuances). 

Format: 5-minute opening per side → 5-minute discussion → 5-minute audience Q&A → live poll - vote on the debate motion.

Case-Based Panel + Audience Interaction:

Rapid Cases (5 minutes each x3)

1. Professional singer with chronic throat clearing and normal EGD: “Treat or test first?”
2. Chronic cough with normal acid exposure but high non-acid events: “Does therapy change?”
3. Mucosal protection: formulations and their place in the management of GERD and LPR
4. Refractory LPS after maximal PPI & alginate: “Is it time for surgery or is it not reflux?”

3 take-home messages aligned to consensus language 

Monday, June 15, 2:00 – 03:30 pm
Auditorium Richelieu

1. Why and when to resect thoracic duct during RAMIE and in which anatomical plane?
2. da Vinci Single Port subcostal Esophagectomy – How to and first results?
3. Cardia cancer – how to treat differently compared to esophageal adenocarcinoma?
4. Vision of Robot Assisted Cervical Esophagectomy (RACE)
5. Results of the randomized prospective multi-center ROBOT-2 Trial of MIE vs RAMIE
6. Different robotic systems for esophageal surgery, where do we go?

Panel Chat/Q&A

Monday, June 15, 4:00 – 05:30 pm
Auditorium Richelieu

1. ICG during RAMIE
2. RAMIE in Middle East – Multiport Results
3. RAMIE in difficult Cases – Proximal esophagus
4. New techniques treating early cancer with robotic surgery vs. endoscopy
5. Benign Foregut – Robotic Update
6. Implementation of AI / Digital Assist in robotic surgery

Panel Chat/Q&A

Monday June 15, 4:00 – 5:30 pm
Auditorium Condé

1. What is the true prevalence of EoE and is it increasing? 
2. What do we know about the microbiome in EoE?
3. How should esophageal biopsies ideally be analyzed for EoE patients?
4. What is the role of allergy testing for EoE patients?
5. Does the presentation and management of EoE differ in South America?
6. What is the role for non-endoscopic techniques for diagnosis & surveillance? 
   
   II. Management
7. ​How to transition EoE patients from pediatric to adult practices? 
8. Is there still a role for proton pump inhibitors in the management of EoE? 
9. Topical steroids: who, what & how long? 
10. How to approach biologic therapies for EoE in 2026? 
11. How I approach endoscopic dilation for EoE 
12. Is EoE therapy forever? 

Tuesday June 16, 9:00 – 10:30 am
Auditorium Richelieu

1. Which classification system we need 2026?                             
2. Double Tract reconstruction after limited resection           
3. How long we can wait after neoadjuvant treatment for surgery and how long we should wait?
4. Which access is the best open, HYBRID or minimal invasive?   
5. What is the safest anastomotic technique after esophagectomy?          
6. How we can prevent and treat Enterothorax after Esophagectomy?      

Panel Chat/Q&A

Tuesday June 16, 9:00 – 11:30 am
Auditorium Condé

Tuesday, June 16, 11:00 am – 12:30 pm
Auditorium Richelieu

1. Is there a place for surgery in proximal cancer?
2. When we need McKeown, when Ivor-Lewis approach is sufficient? 
3. What is necessary extent of lymphadenectomy in thoracic esophageal cancer?
4. Technical aspects of cervical anastomosis after McKewon esophagectomy?
5. What are the arguments for surgery in squamous cell carcinoma?
6. What are the pitfalls for salvage esophagectomy?

Panel Chat/Q&A

Tuesday June 16, 11:00 am – 12:30 pm
Auditorium Condé

Tuesday June 16, 2:00 – 3:30 pm
Auditorium Richelieu

1. Do we really know what causes EoE?
2. Is EoE really a new disease or just unrecognized previously?
3. How should one ideally pursue an EoE-elimination diet?
4. How to approach medical therapy for EoE: my algorithm?
5. What is the role for artificial intelligence in EoE?
6. How will we treat EoE in 10 years?

Panel Chat/Q&A

Tuesday June 16, 2:00 – 3:30 pm
Auditorium Condé

1. Dynamic Esophageal Radiology
2. Benign stenosis: measurements for treatment
3. Dynamic Radiology in esophageal carcinoma
4. Dynamic Radiology of the PE segment: the perspective of surgery
5. Dynamic Radiology: the perspective of bariatric surgery
6. Dynamic Radiology: the gastroenterologic perspective             

Panel Chat/Q&A

Tuesday, June 16, 4:00 – 5:30 am
Auditorium Lulli

1. ESMO standards of care: equal to other countries in the world?
2. Biomarker in advanced esophageal cancers: what do we need to know 
3. IO tailored personalized medicine included side effects, drug holidays and maintenance
4. Does Microbiome, helicobacter eradication or antibiotics help or worsen chemo and IO therapy–regional differences in clinical characteristics and treatment strategies" 
5. Oligometastatic disease: recommendations or studies ahead? 
6. What’s new on Bispecific Antibodies, T-cell engager, Innovative Biomarkers and Vaccines?
7. Gender medicine: already prime time?
8. Young or old: Do we differentiate in intensity of care
9. ASCO 2026: important news and approvals ahead? 
10. Artificial intelligence (AI) as a practical decision support tool for oncologists: ready for prime time 

Tuesday, June 16, 4:00 – 5:30 pm
Auditorium Richelieu

1. When do PPI fail and when should PCAB be considered in treating reflux symptoms?
2. How should reflux symptoms refractory to PPI be evaluated?
3. What other primary or adjunctive non-surgical options are useful for reflux symptoms?
4. What are the causes of failed fundoplication?
5. How should symptomatic post-fundoplication patients be assessed?
6. When should endoscopic anti-reflux interventions be considered?

Panel Chat/Q&A

Tuesday June 16, 4:00 – 5:30 am
Auditorium Condé

Panel Chat/Q&A

Wednesday, June 17, 9:00 – 10:30 am
Auditorium Lulli

1. When to FLIP – up-front, at the end, any time, or never?
2. Advantages of barium esophagram versus FLIP for EGJ outflow obstruction 
3. Achalasia subtyping: FLIP + Barium versus HREM alone 
4. Achalasia treated, recurrent – how to evaluate? 
5. Achalasia treated, recurrent – recut or dilate? 
6. Treatment of spastic disorders in the esophagus (non-achalasia): pharmacologic versus endoscopic interventions
7. Only time for one provocative maneuver today – how do you choose – MRS, Rapid drink or SLR? 
8. Treatment or observation for Ineffective Esophageal Motility, which is better? 
9. Pre-operative testing for GERD: esophageal manometry AND imaging or is less more?  
10. Absent contractility and proven GERD: lifestyle modification and medical management or wrap? 
11. Should we care more or less about bolus clearance during HREM? 
12. An abnormal looking manometry that is NORMAL by Chicago 4.0 – Explore or ignore?

Wednesday, June 17, 9:00 – 10:30 am
Auditorium Richelieu

1. Current Art of Antireflux Surgery
2. Current Art of Surgery for Achalasia
3. Current Art of Surgery for Esophageal Diverticula
4. Current Art of Surgery for Esophageal Squamous Cell Carcinoma
5. Current Art of Surgery for Esophageal and Junctional Adenocarcinoma

Panel Chat/Q&A

Wednesday, June 17, 11:00 am – 12:30 pm
Auditorium Lulli

1. How does obesity impact esophageal physiology? 
2. Should esophageal physiologic testing be routinely performed prior to bariatric intervention?
3. How should dysphagia following bariatric surgery be evaluated? 
4. Can bariatric surgery cause achalasia and achalasia-like disorders? 
5. How do weight regain and associated interventions affect esophageal symptoms? – 
6. What are the consequences of intragastric balloons on esophageal and gastrointestinal symptoms? 
7. What are the mechanisms underlying excessive reflux following bariatric surgery? 
8. How should reflux following bariatric surgery be managed? 
9. What is the approach to a hiatal hernia following bariatric surgery? 
10. Do endoscopic gastric remodeling procedures cause esophageal symptoms? 
11. What are the esophageal and gastrointestinal side effects of GLP-1 receptor agonist use? 
12. What is the impact of obesity and weight loss interventions on the risk of Barrett’s esophagus and esophageal cancer? 

Wednesday, June 17, 11:00 am – 12:30 pm
Auditorium Richelieu

Panel Chat/Q&A

Wednesday, June 17, 2:00 – 3:30 pm
Auditorium Lulli

1. How should the optimal reflux monitoring modality and protocol be selected for different reflux presentations?
2. Can patients with AET <4% off PPI have actionable GERD?
3. How should reflux-symptom association data on reflux monitoring tests be used for planning symptom management?
4. Is there a role for anti-reflux therapy in treating reflux hypersensitivity
5. The AET is 4-6% off PPI – now what?
6. Can total reflux episode count on impedance monitoring direct management?
7. What methods are available for clinical measurement of esophageal mucosal integrity?
8. What are the roles of mucosal impedance metrics in evaluating typical and atypical reflux symptoms?
9. Are there roles for barium esophagram and high-resolution manometry in GERD evaluation?
10. How can FLIP be utilized for GERD diagnosis and management?
11. What is the diagnostic approach to suspected reflux-related airway diseases?
12. How can reflux management protect the lungs in pre- and post-transplant patients?

Wednesday, June 17, 2:00 am – 3:30 pm
Auditorium Richelieu

Wednesday, June 17, 2:00 – 3:30 am
Auditorium Condé

(speakers will continue to be added as they are confirmed)

• Nitin Ahuja (University of Pennsylvania, USA) (GI)
• Hiroyuki Aihara (Brigham and Women’s Hospital, Harvard Medical School, USA) (GI)
• Jacqui Allen (University of Auckland, New Zealand) (ENT)
• Aymen AlMuhaidb (King Faisal Specialist Hospital, Saudi Arabia) (GI)
• Thierry Andre (Hospital Saint-Antoine, Paris) (Oncology)
• Daphne Ang (Changi General Hospital, Singapore) (GI)
• Ahmad Najdat Bazarbashi (King Faisal Specialist Hospital, Saudi Arabia) (GI)
• Alberto Barchi (IRCCS San Raffaele Scientific Institute, Italy) (GI)
• Reg Bell (Past President, American Foregut Society) (Surgery)
• Irit Ben-Aharon (Rambam Health Care Campus, Israel) (Oncology)
• Felix Berlth (Universitätsklinik Tübingen, Germany) (Surgery)
• Katharina Beyer (Universitätsklinikum Augsburg, Germany) (Surgery)
• Shobna Bhatia (HBT Medical College Mumbai, India) (GI)
• Martin Birchall (University College London, UK) (ENT)
• ​Jonathan Bock (Medical College of Wisconsin, USA) (ENT)
• Serhat Bor (Ege University, Turkey) (GI)
• Baruch Brenner (Rabin Medical Center, Israel) (Oncology)
• Marcia Canto (Johns Hopkins University, USA) (GI)
• Thomas L. Carroll (Brigham and Women’s Hospital, Harvard Medical School, USA) (ENT)
• Walter W. Chan (Brigham and Women’s Hospital, Harvard Medical School, USA) (GI)
• Kenneth Chang (Hoag Health, USA) (GI)
• Ian Chau (The Royal Marsden – NHS Foundation Trust, UK) (Oncology)
• Chien-Lin (Harry) Chen (Hualien Tzu Chi Hospital, Tzu Chi University, Taiwan) (GI)
• Joan Chen (University of Michigan, USA) (GI)
• Judy Chen (University of Washington, USA) (Surgery)
• Philip Chiu (Chinese University of Hong Kong, Hong Kong SAR) (Surgery)
• Yu Kyung Cho (The Catholic University of Korea, Korea) (GI)
• Reena Chokshi (Baylor College of Medicine, USA) (GI)
• Seung-hun Chon (University Hospital of Cologne, Germany) (Surgery)
• Daniel Cisternas (Facultad de Medicina Clínica Alemana Universidad del Desarrollo, Chili) (GI)
• John O. Clarke (Stanford University School of Medicine, USA) (GI)
• Don Codipilly (Mayo Clinic, USA) (GI)
• Yaniv Cozacov (Horizon Health, USA) (Surgery)
• Enrique Coss-Adame (Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán", Mexico) (GI)
• Tanuja Damani (NYU, USA) (Surgery)
• Nicola de Bortoli (University of Pisa, Italy) (GI)
• Christelle De la Fouchardiere (Institut PAOLI-CALMETTES, Marseille, France) (Oncology)
• Massimiliano Di Pietro (University of Cambridge, UK) (GI)
• Kerry Dunbar (University of Texas Southwestern, USA) (GI)
• Jorge Luis Espinoza Rios (Cayetano Heredia Medical School, Peru) (GI)
• Micaela Esquivel (Stanford University School of Medicine, USA) (Surgery)
• Vincent Wentao Fang (Shanghai East Hospital, China) (Surgery)
• Medhat Fanous (Aspirus Iron River Hospitals and Clinics, USA) (Surgery)
• Ronnie Fass (MetroHealth Medical Center, Case Western Reserve University, USA) (GI)
• Nielsen Fernandez-Becker (Stanford University, USA) (GI)
• Mark Fox (University Hospital Zurich and Klinik Arlesheim, Switzerland) (GI)
• Shai Friedland (Stanford University School of Medicine, USA) (GI)
• Sravanya Gavini (The University of Texas Southwestern, USA) (GI)
• Gaurav Ghosh (Cornell, USA) (GI)
• Ines Gockel (University Hospital and Clarahospital of Basel, Switzerland) (Visceral Surgery)
• Simone Giacopuzzi (University of Verona, Italy) (Surgery)
• Suzanne Gisbertz (Amsterdam UMC, Holland) (Surgery)
• Nirmala Gonsalves (Northwestern University, USA) (GI)
• Jonathan Gould (Medical College of Wisconsin, USA) (Surgery)
• Robert Giuli (OESO, France) (Surgery)
• Peter Grimminger (University Medical Center Mainz, Germany) (Surgery)
• Livia Guadagnoli (Northwestern Feinberg School of Medicine, USA) (Psychology)
• Christian Gutschow (Universitätsspital Zürich, Switzerland) (Surgery)
• C. Prakash Gyawali (Washington University School of Medicine, USA) (GI)
• Albis Hani (Pontificia Universidad Javeriana, Colombia) (GI)
• Joo Ha Hwang (Stanford, USA) (GI)
• Brent Hiramoto (University of Southern California, USA) (GI)
• Daikō Hiroyki (National Cancer Center Hospital, Japan) Surgery
• Arnulf Hölscher (Elisabeth-Krankenhaus-Essen GmbH, Germany) (Surgery)
• Toshitaka Hoppo (Rutgers Robert Wood Johnson Medical School, USA) (Surgery)
• Jennifer Horsley-Silva (Mayo Clinic, USA) (GI)
• Inna Husain (Indiana University School of Medicine, USA) (ENT)
• Joo Ha Hwang (Stanford University School of Medicine, USA) (GI)
• Prasad Iyer (Mayo Clinic, USA) (GI)
• Yan Jiang (Stanford University School of Medicine, USA) (GI)
• Pichamol Jirapinyo (Brigham and Women’s Hospital, Harvard Medical School, USA) (GI)
• Daniela Jodorkovsky (Mount Sinai School of Medicine, USA) (GI)
• Nikki Johnston (Medical College of Wisconsin, USA) (ENT)
• Kee Wook Jung (University of Ulsan, Korea) (GI)
• Minoa Jung (Hôpitaux Universitaires de Genève, Switzerland) (Surgery)
• Allon Kahn (Mayo Clinic, USA) (GI)
• Anthony Kalloo (Johns Hopkins University, USA) (GI)
• Afrin Kamal (Stanford University School of Medicine, USA) (GI)
• Priya Kathpalia (University of California San Francisco, USA) (GI)
• Ronan Kelly (Baylor Scott White, USA) (Oncology)
• Courtney Kemp (Twin Cities Heartburn Center, USA) (Surgery)
• Abraham Khan (New York University Langone School of Medicine, USA) (GI)
• Mouen Khashab (Johns Hopkins University, USA) (GI)
• Do Hoon Kim (University of Ulsan, Korea) (GI)
• Dagmar Kollman (University of Vienna, Austria) (Surgery)
• Do Hoon Kim (University of Ulsan, Korea) (GI)
• Vani Konda (Baylor Scott and White Health, USA) (GI)
• Yusef Kudsi (Harvard University, USA) (Surgery)
• Braden Kuo (Columbia University Vagelos College of Physicians and Surgeons, USA) (GI)
• Adriana Lazarescu (University of Alberta, Canada) (GI)
• Jerome R. Lechien (Université de Mons, Belgium) (ENT)
• Ju Yup Lee (Keimyung University, Korea) (GI)
• Sang Kil Lee (Yonsei University, Korea) (GI)
• Yeong Yeh Lee (Universiti Sains Malaysia, Malaysia) (GI)
• Wai-Kit Lo (Brigham and Women’s Hospital, Harvard Medical School, USA) (GI)
• Nayna Lodhia (Brigham and Women’s Hospital, Harvard Medical School, USA) (GI)
• Sara Lonardi (Veneto Institute of Oncology IOV, Italy) (Oncology)
• Kristle Lynch (University of Pennsylvania, USA) (GI)
• Pavan Mallur (Harvard University, USA) (ENT Surgery)
• Stella Mantziari (CHU de Lille, FR) GI
• Sheraz Markar (Univeristy of Oxford, UK)
• Sheraz Markar (University of Oxford, UK) (Surgery)
• Hiroshi Mashimo (Harvard University, USA) GI
• Tomoaki Matsumura (Chiba University Hospital, Japan) (GI)
• Emily McGowan (University of Virginia, USA) (Allergy)
• Calies Menard-Katcher (Childrens Colorado USA) (GI)
• Paul Menard-Katcher (University of Colorado USA) (GI)
• Jean-Philippe Metges (CHU de Brest, France) (Oncology)
• Markus Moehler (Johannes-Gutenberg University, Germany) (Oncology)
• Andres Francisco Navarrete Molina (Clínica Alemana, Chile) (Surgery)
• Stefan Mönig (Hôpitaux Universitaires de Genève, Switzerland) (Surgery)
• Jacob Moremen (University of Mississippi Medical Center, USA) (Surgery)
• Mayssan Muftah (Brigham and Women’s Hospital, Harvard Medical School, USA) (GI)
• Amanda Muir (Children’s Hospital of Philadelphia, University of Pennsylvania, USA) (GI)
• Beat Müller (University Digestive Healthcare Center Basel, Switzerland) (Surgery)
• Anh Nguyen (Baylor University Medical Center of Dallas, USA) (GI)
• Mark Noar (Endometriosis and Neuroenterology Research Institute, USA) (GI)
• Radka Obermannova (Masaryk Memorial Cancer Institute, CZ) (Oncology)
• Jung-Hwan Oh (The Catholic University of Korea, Korea) (GI)
• Oliver Old (Gloucestershire Hospitals NHS Foundation Trust, UK) (Surgery)
• Darshan Parekh (Mumbai Institute of Gastroenterology, India) (GI)
• Moo In Park (Kosin University, Korea) (GI)
• Walter Park (Stanford University School of Medicine, USA) (GI)
• Sylvana Peretta (Université de Strasbourg, France) (Surgery)
• Guillaume Piessen (CHU de Lille, France) (Surgery)
• Peter Pokieser (Medical University of Vienna, Austria) (Radiology)
• Shaun Preston (Royal Surrey NHS, UK) (Surgery)
• Alberto Puccini (IRCCS Humanitas Research Hospital, Italy) (Oncology)
• Daryl Ramai (University of Utah, USA) (GI) 
• Karthik Ravi (Mayo Clinic, USA) (GI)
• William Ravich (Yale University School of Medicine, USA) (GI)
• José María Remes Troche (Universidad Veracruzana, Mexico) (GI)
• Sun Young Rha (Yonsei University College of Medicine, Korea) (Oncology)
• Megan Riehl (University of Michigan, USA) (Psychology)
• Benjamin Rogers (University of Louisville, USA) (GI)
• Sabine Roman (CHU Lyon, France) (GI)
• Riccardo Rosati (IRCCS San Raffaele Scientific Institute and San Raffaele Vita-Salute University, Italy) (Surgery)
• Sallum Rubens (University of Sao Paolo, Brazil) (Surgery)
• Renato Salvador (University of Padua, Italy) (Surgery)
• Santosh Sanagapali (St. Vincent’s Hospital, University of New South Wales, Australia) (GI)
• Netu Sarkaria (UT Southwestern, USA) (Surgery)
• Bryan Sauer (University of Virginia, USA) (GI)
• Edoardo Savarino (University of Padua, Italy) (GI)
• Akinari Sawada (Osaka Metropolitan University, Japan) (GI)
• Carmelo Scarpignato (United Campus of Malta, Malta) (Pharmacology)
• Christoph Schlag (University Hospital Zurich, Switzerland) (GI)  
• Sebastian Schoppmann (Medical University of Vienna, Austria) (Surgery)
• Allison Schulman (University of Michigan, USA) (GI)
• Jordi Serra (University Hospital Vall d'Hebrón, Spain) (GI)
• Eric Shah (University of Michigan, USA) (GI)
• Eric Sheu (Brigham and Women’s Hospital, Harvard Medical School, USA) (Surgery)
• Eun Ji Shin (Johns Hopkins University, USA) (GI)
• Stefano Siboni (IRCCS Policlinico San Donato, University of Milan, Italy) (Surgery)
• Daniel Sifrim (Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK) (GI)
• Joshua Sloan (University of Minnesota, USA) (GI)
• Michael Smith (Mount Sinai School of Medicine, USA) (GI)
• Diana Snyder (Mayo Clinic, USA) (GI)
• Renato Soares (Hospital Santa Cruz, Curtiba, Brazil) (Surgery)
• Irene Sonu (Stanford University School of Medicine, USA) (GI)
• Marco Sozzi (IRCCS Policlinico San Donato, University of Milan, Italy) (Surgery)
• Ellen Stein (Rutgers University, USA) (GI)
• Lee Swanström (Institutes des Hôpitaux Universitaires, University of Strasbourg, France) (Surgery)
• Roger Tatum (University of Washington, USA) (GI)
• Salvatore Tolone (University of Campania Luigi Vanvitelli, Italy) (Surgery)
• David Tougeron (CHU de Poitiers, France) (Oncology)
• Ping-Huei Tseng (National Taiwan University, Taiwan) (GI)
• Luis Raúl Valdovinos García (Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico) (GI)
• Kenneth Vega (Prisma Health, USA) (GI)
• Marcelo Vela (Mayo Clinic, USA) (GI)
• Pierfrancesco Visaggi (University of Pisa, Italy) (GI)
• Russell White (Tenwek Hospital, Kenya) Surgery
• Ian Wong (Queen Mary Hospital, Hong Kong) Surgery
• Marc Wong (Chinese University of Hong Kong, Hong Kong SAR) (GI)
• Andrew Wright (University of Washington) Surgery
• Justin Wu (Chinese University of Hong Kong, Hong Kong SAR) (GI)
• Robert Yates (University of Washington) Surgery
• Aziz Zaanan (European George Pompidou Hospital, University of Paris Cite, France) (Oncology)
• Frank Zerbib (Bordeaux University, France) (GI)
• Adam Zeyara (Lund University, Sweden) (Surgery)
• Margaret Zhou (Stanford, USA) (GI)